
News|Articles|May 23, 2024
Don’t underestimate the "small stuff"
Author(s)Eurofins BioPharma Product Testing
Learn about the importance of considering human factors testing beyond the initial validation phase. Through two case studies, it illustrates how seemingly minor product changes can trigger regulatory scrutiny. The message is clear: proactive testing and expert guidance are essential to navigate regulatory requirements effectively.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Syngene Extends Major Research Collaboration with BMS
2
Sharp Expands European Injectable Packaging Capacity With €20 million Investment
3
The Shift from Containment to Protection: Packaging Trends Impacting Pharma
4
State of the Bio/Pharma Workforce: A Comparative Analysis of Employment Trends and Industry Sentiment
5